Ceo
CurrentAt 100XBIO we strive to deliver 100x more data on antigen specificity of the T cells in the limited sample volume (blood, tumor, lymph nodes), and as the downstream -- confirming the cells' phenotype and cytokine expression. All automated.Looking for (1) early investments, (2) R&D partners, and (3) early academia, biotech and pharma clients. We are raising $500K of pre-seed investment, and raised over $200K.***I have over 15 years of experience in building, expanding, and managing immunology labs. I self-led my Ph.D. and raised the scientific output of my institute to the next level, leaving after myself a well-equipped cell culture lab and mouse research facility. Selection of suitable equipment, suitable research methods, method development, and method optimization -- were always a pleasure to me.I have huge experience establishing scientific collaborations including international -- keeping in mind the best interest of both partnering parties in the long run. Teaching my colleagues and learning from them is an essential part of my job. Do they work in my lab, or overseas -- doesn't matter, we are all in the process of educating ourselves. I'm always thankful if you tell me where I'm wrong.My current task is to test the beautiful scientific and business hypotheses leading to better immuno-oncology tools, vaccines, & more. To execute this mission I need to get the company funded and the first projects started. I had a lot of failed scientific projects before and I have a strong feel for what's reliable. Step by step our technology starts working, and I sincerely hope it makes a global impact.